Lung-on-a-chip Market
Lung on a chip. The device is made using human lung and blood vessel cells and it can predict absorption of airborne nanoparticles and mimic the inflammatory response triggered by microbial pathogens. It can be used to test the effects of environmental toxins, absorption of aerosolized therapeutics, and the safety and efficacy of new drugs.
The global Lung-on-a-chip market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Lung-on-a-chip is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Lung-on-a-chip is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Lung-on-a-chip in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Lung-on-a-chip include Emulate, Tissuse, Hesperos, CN Bio Innovations, Draper Laboratory, Mimetas, Nortis, Kirkstall and Cherry Biotech SAS, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lung-on-a-chip, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung-on-a-chip.
The Lung-on-a-chip market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lung-on-a-chip market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung-on-a-chip companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
Key Segmentations
By Company
- Emulate
- Tissuse
- Hesperos
- CN Bio Innovations
- Draper Laboratory
- Mimetas
- Nortis
- Kirkstall
- Cherry Biotech SAS
- Else Else Kooi Laboratory
- Micronit Microtechnologies B.V.
Segment by Type
- Pulmonary Inflammation
- Pulmonary Infection
Segment by Application
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Other End Users
0 Comments